OPTIMIZATION OF SECOND-LINE TARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA CANCER AFTER USE OF VEGF RECEPTOR – TYROSINE KINASE INHIBITORS (LITERATURE REVIEW)

by R. V. Savkov
Published 2014-08-01

OPTIMIZATION OF SECOND-LINE TARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA CANCER AFTER USE OF VEGF RECEPTOR – TYROSINE KINASE INHIBITORS (LITERATURE REVIEW)

by R. V. Savkov
Published 2014-08-01

Results and analysis of the application of a consistent targeted therapy in patients with metastatic renal cell carcinoma in Moscow (for the period from June 2005 to July 2015)

by V. I. Shirokorad, G. P. Kolesnikov, S. V. Kostritskiy, K. Yu. Kashintsev, D. V. Dolgikh
Published 2016-09-01

Review of the Proceedings of the European Society for Medical Oncology (ESMO) 2017 Congress

by A. A. Kirichek, B. Sh. Kamolov, V. B. Matveev
Published 2018-01-01